The price of Pradaxa (dabigatran etexilate) can vary significantly based on several factors, including the dosage, the pharmacy, insurance coverage, and whether a generic version is available.
How much does a Pradaxa prescription cost without insurance?
Without insurance, the retail price for a 30-day supply of Pradaxa can range from approximately $300 to over $600 for common dosages like 110 mg or 150 mg [1]. Prices may differ between pharmacies and for different strengths of the medication.
What are the costs for Pradaxa with insurance?
Insurance coverage for Pradaxa can substantially reduce out-of-pocket expenses. The actual cost to a patient with insurance depends on their specific plan, including their copay or deductible. Some insurance plans may place Pradaxa on a higher tier, leading to higher copayments. Patient assistance programs may also be available to help offset costs for those with financial limitations [2].
When might a generic version of Pradaxa become available?
The patent protection for Pradaxa is a key factor in the availability and pricing of generic alternatives. DrugPatentWatch.com tracks patent expirations for medications. While specific patent expiry dates can be complex and subject to litigation, the general trend is that once primary patents expire, generic manufacturers can seek approval to market their versions of the drug, often leading to lower prices [3].
How do Pradaxa prices compare to other blood thinners?
Pradaxa is a direct oral anticoagulant (DOAC). Its pricing can be compared to other DOACs like Xarelto (rivaroxaban), Eliquis (apixaban), and Savaysa (edoxaban), as well as older anticoagulants like warfarin. Prices for these medications also vary based on dosage, insurance, and generic availability. Generally, as generic versions of DOACs become available, their prices tend to decrease, potentially influencing the market price of branded alternatives.
Can Pradaxa prices change over time?
Yes, medication prices can change. Factors influencing price shifts include manufacturing costs, market demand, competition from generics, and pharmaceutical company pricing strategies. The introduction of a generic version of Pradaxa would likely lead to a decrease in the overall market price for dabigatran etexilate [3].
Sources:
[1] https://www.goodrx.com/pradaxa
[2] https://www.pradaxa.com/managing-your-treatment/financial-assistance
[3] https://drugpatentwatch.com/